http://www.akebia.com
Akebia Therapeutics, Inc. Company Intro
Fully integrated renal biopharmaceutical company with a late stage product in global Phase 3 clinical development and a commercially available medicine.
Industry
Healthcare
Akebia Therapeutics, Inc. Headquaters
245 First Street
Cambridge,02142
United States
Akebia Therapeutics, Inc. Share price
26 Jan 2021 01:03 GMT
$3.4800
0.12 (3.57 %)
Akebia Therapeutics, Inc. Market cap
$536.24 M
WMC RANKING
2021
Akebia Therapeutics, Inc. # 25
BiotechnologyLatest Akebia Therapeutics, Inc. News
25 Jan 2021
Global Iron-Deficiency Anemia Therapy Market Analysis ...
ViforPharma Ltd; AMAG Pharmaceuticals; Fresenius SE & CO KGAA; Sanofi; Novartis AG; ABBVIE INC. Akebia Therapeutics, INC; CHO-A Pharmaceutical CO., ...
25 Jan 2021
Is Akebia Therapeutics Inc (AKBA) a Stock to Watch This Week?
Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney ...
25 Jan 2021
Hematopoietic Agents Market To Witness Relatively ...
PHARMACOSMOS A/S, Akebia Therapeutics, Inc., Allergan., Sanofi., Hikma Pharmaceutical PLC., Amgen Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd.
WMC Market Score
WMC Market to Revenue Score
Akebia Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Akebia Therapeutics, Inc. | USD | $325,296 | $491,894 | $-245,230 | $4,857M | 25 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $573,840B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $349,360B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $617,820B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $272,080B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Akebia Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Akebia Therapeutics, Inc. Post vs Top 4 Industry Competitors
Akebia Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Akebia Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Akebia Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Akebia Therapeutics, Inc. | 3.52 | 2.03 | 21.50 | 0 | 0 | 0 | 12.15 |
| Regeneron Pharmaceuticals, Inc. | 100 | 66.54 | 29.44 | 100 | 0 | 0 | 100 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.37 | 100 | 60 | 0 | 0 | 90.05 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 8.77 | 86 | 0 | 0 | 99.30 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
